A Phase I/Ib Trial of Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
Latest Information Update: 18 Jul 2024
At a glance
- Drugs Pirfenidone (Primary) ; Carboplatin; Paclitaxel; Pemetrexed
- Indications Adenocarcinoma; Carcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Jul 2024 Planned End Date changed from 1 Jun 2024 to 1 Sep 2024.
- 13 Jul 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.
- 27 May 2022 Planned End Date changed from 1 Jun 2022 to 1 Jun 2023.